Medpace Holdings, Inc. (MEDP)
622.03
+1.55
(+0.25%)
USD |
NASDAQ |
Sep 16, 14:26
Medpace Holdings Enterprise Value : 16.92B for Sept. 15, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 15, 2026 | 16.92B |
| September 14, 2026 | 16.22B |
| September 11, 2026 | 16.00B |
| September 10, 2026 | 15.88B |
| September 09, 2026 | 15.96B |
| September 08, 2026 | 16.09B |
| September 04, 2026 | 16.10B |
| September 03, 2026 | 16.16B |
| September 02, 2026 | 16.15B |
| September 01, 2026 | 15.88B |
| August 31, 2026 | 16.18B |
| August 28, 2026 | 16.36B |
| August 27, 2026 | 16.67B |
| August 26, 2026 | 16.88B |
| August 25, 2026 | 16.74B |
| August 24, 2026 | 16.90B |
| August 21, 2026 | 16.92B |
| August 20, 2026 | 16.70B |
| August 19, 2026 | 16.58B |
| August 18, 2026 | 16.08B |
| August 17, 2026 | 16.27B |
| August 14, 2026 | 15.75B |
| August 13, 2026 | 15.84B |
| August 12, 2026 | 16.26B |
| August 11, 2026 | 16.50B |
| Date | Value |
|---|---|
| August 10, 2026 | 16.41B |
| August 07, 2026 | 16.09B |
| August 06, 2026 | 15.93B |
| August 05, 2026 | 16.00B |
| August 04, 2026 | 15.65B |
| August 03, 2026 | 15.60B |
| July 31, 2026 | 15.71B |
| July 30, 2026 | 15.74B |
| July 29, 2026 | 15.93B |
| July 28, 2026 | 15.54B |
| July 27, 2026 | 16.05B |
| July 24, 2026 | 16.38B |
| July 23, 2026 | 16.51B |
| July 22, 2026 | 14.34B |
| July 21, 2026 | 14.44B |
| July 20, 2026 | 14.34B |
| July 17, 2026 | 14.61B |
| July 16, 2026 | 14.62B |
| July 15, 2026 | 14.38B |
| July 14, 2026 | 14.57B |
| July 13, 2026 | 14.40B |
| July 10, 2026 | 14.63B |
| July 09, 2026 | 14.55B |
| July 08, 2026 | 14.45B |
| July 07, 2026 | 14.85B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| IQVIA Holdings, Inc. | 58.68B |
| Charles River Laboratories International, Inc. | 15.89B |
| Avantor, Inc. | 13.84B |
| Champions Oncology, Inc. | 73.57M |
| Personalis, Inc. | 1.538B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 121.36M |
| Revenue (Quarterly) | 707.33M |
| Total Expenses (Quarterly) | 585.97M |
| EPS Diluted (Quarterly) | 4.250 |
| Gross Profit Margin (Quarterly) | 27.56% |
| Profit Margin (Quarterly) | 17.16% |
| Earnings Yield | 2.74% |
| Operating Earnings Yield | 3.25% |
| Normalized Earnings Yield | 2.741 |